摘要
目的 经肝动脉单纯抗癌药物灌注 (TAI)与化疗栓塞 (TAE)治疗中、晚期肝癌 ,观察比较TAI和TAE治疗中、晚期肝癌的疗效。方法 选取中、晚期肝癌患者 5 9例 ,第一组 (18例 )行单纯肝A灌注化疗 ,第二组 (4 1例 )为肝A化疗栓塞组。结果 (1)AFP值降低 :TAI组为 4 7.4 % ,TAE组为 77.8% ;(2 )肿瘤缩小率 :TAI组为 33.3% ,TAE组为 6 3.4 % ;(3)生存率 :TAI组一年生存率为 11.1% ,TAE组则为 6 3.4 %。结论 经导管肝A化疗加栓塞是治疗中、晚期肝癌行之有效的非手术疗法。
Objective To treat metaphase and Late hepatic cancer with antineoplastic perfusion (TAI) and chemotherapy combined embolization(TAE)via hepatic avteria and analyzed. Methods To select 59 patients with metaphase and Late hepatic cancer and radomly provided to perfusion group and chemotherapy combined embolization group. Results (1)AFP Value in TAI and TAE were 47.4% and 77.8% respectively;(2)Focus minify rate: TAI 33.3% TAE: 63.4%.(3) Survival rate:TAI 11.1%, TAE 63.4%. Conclusion Chemotherapy combined embolization via hepatic arteria is an effective and no-operative method to treat metaphase and late hepatic cancer.
出处
《青海医学院学报》
CAS
2004年第1期36-37,共2页
Journal of Qinghai Medical College
关键词
肝癌
动脉灌注
化疗栓塞
疗效
Hepatic cancer Antineoplastic pefusion Chemotherapy cambine embolization Treatment effect
